We are live on ! Find out more
Dowling & Yahnke

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+14.02%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
+$158M
Cap. Flow
-$1.2M
Cap. Flow %
-0.09%
Top 10 Hldgs %
25.79%
Holding
334
New
27
Increased
115
Reduced
154
Closed
6
Avg Time Held
4.6 years
Top 10 Avg Time Held
3.2 years
Top 20 Avg Time Held
3.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.42%
2 Technology 17.34%
3 Healthcare 12.27%
4 Financials 10.7%
5 Consumer Staples 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VEA icon
151
Vanguard FTSE Developed Markets ETF
VEA
$228B
$1.96M 0.14%
41,468
-8,698
-17% -$383K
2013 Q2
30 quarters
VUG icon
152
Vanguard Morningstar Growth ETF
VUG
$227B
$1.95M 0.14%
46,110
-9,192
-17% -$367K
2013 Q2
30 quarters
VIS icon
153
Vanguard Industrials ETF
VIS
$8.03B
$1.91M 0.14%
11,222
-241
-2% -$38.6K
2019 Q1
7 quarters
FISV icon
154
Fiserv Inc
FISV
$25.3B
$1.9M 0.14%
16,680
+4
+0% +$431
2013 Q2
30 quarters
GD icon
155
General Dynamics
GD
$93.1B
$1.86M 0.13%
12,482
+234
+2% +$34.2K
2013 Q2
30 quarters
IWM icon
156
iShares Russell 2000 ETF
IWM
$76.2B
$1.77M 0.13%
9,049
-1,858
-17% -$325K
2013 Q2
30 quarters
AFL icon
157
Aflac
AFL
$60.1B
$1.74M 0.12%
39,195
-674
-2% -$27.6K
2019 Q2
6 quarters
BIIB icon
158
Biogen
BIIB
$34.4B
$1.73M 0.12%
7,075
-222
-3% -$57.3K
2013 Q2
30 quarters
CSX icon
159
CSX Corp
CSX
$90.2B
$1.71M 0.12%
56,640
-1,875
-3% -$53.9K
2014 Q4
24 quarters
BAX icon
160
Baxter International
BAX
$13.1B
$1.69M 0.12%
21,084
-510
-2% -$40.4K
2019 Q2
6 quarters
OEF icon
161
iShares S&P 100 ETF
OEF
$20.4B
$1.68M 0.12%
9,805
– –
2016 Q2
18 quarters
AIG icon
162
American International
AIG
$42.2B
$1.63M 0.12%
43,049
-598
-1% -$21.1K
2019 Q2
6 quarters
ILMN icon
163
Illumina
ILMN
$39.6B
$1.61M 0.11%
4,477
-520
-10% -$166K
2015 Q4
20 quarters
ACWX icon
164
iShares MSCI ACWI ex US ETF
ACWX
$17.4B
$1.58M 0.11%
29,769
-900
-3% -$44.6K
2020 Q1
3 quarters
EFG icon
165
iShares MSCI EAFE Growth ETF
EFG
$14.9B
$1.58M 0.11%
15,614
-2,825
-15% -$267K
2013 Q2
30 quarters
VOO icon
166
Vanguard S&P 500 ETF
VOO
$1.03T
$1.56M 0.11%
4,552
+2,317
+104% +$755K
2014 Q1
27 quarters
SCZ icon
167
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
$1.53M 0.11%
22,361
-8,115
-27% -$512K
2013 Q2
30 quarters
EEM icon
168
iShares MSCI Emerging Markets ETF
EEM
$29.1B
$1.52M 0.11%
29,442
-3,252
-10% -$156K
2013 Q2
30 quarters
SNAP icon
169
Snap
SNAP
$10.4B
$1.52M 0.11%
30,271
+3,943
+15% +$164K
2019 Q2
6 quarters
EA icon
170
DELISTED
Electronic Arts
EA
$1.49M 0.11%
10,360
-179
-2% -$23.1K
2017 Q1
15 quarters
ADSK icon
171
Autodesk
ADSK
$50.1B
$1.47M 0.1%
4,803
+174
+4% +$45.9K
2019 Q4
4 quarters
F icon
172
Ford
F
$49.6B
$1.46M 0.1%
166,148
+660
+0.4% +$5.53K
2013 Q2
30 quarters
MAR icon
173
Marriott International
MAR
$101B
$1.42M 0.1%
10,785
-35
-0.3% -$4K
2013 Q2
30 quarters
O icon
174
Realty Income
O
$53.1B
$1.38M 0.1%
22,870
+1,919
+9% +$113K
2017 Q4
12 quarters
ISRG icon
175
Intuitive Surgical
ISRG
$151B
$1.34M 0.1%
4,911
+354
+8% +$87.9K
2018 Q4
8 quarters

Similar funds

Dowling & Yahnke's Q4 2020 Portfolio in Review

As of Q4 2020, Dowling & Yahnke held 334 positions worth $1.4B, up 13% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q4 2020 filing shows 27 new, 115 increased, 154 reduced and 6 closed positions. Its largest new stake was Vanguard Total World Stock ETF: 27,592 shares worth $2.55M. The largest sale was Ionis Pharmaceuticals, an estimated $4.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2020 buy was Vanguard Total World Stock ETF: 27,592 shares worth $2.55M.
  • Dowling & Yahnke added most to Vanguard Emerging Markets Government Bond ETF in Q4 2020, an estimated $2.14M increase.
  • Dowling & Yahnke's biggest Q4 2020 reduction was Ionis Pharmaceuticals, cutting an estimated $4.98M.
  • Dowling & Yahnke fully exited Schrodinger in Q4 2020, selling an estimated $467K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.4B portfolio in Q4 2020.
  • Dowling & Yahnke opened 27 new positions and closed 6 in Q4 2020.
  • Dowling & Yahnke's portfolio value rose 13% quarter-over-quarter to $1.4B.

Based on Dowling & Yahnke's 13F filing for Q4 2020, filed 28 Jan 2021.